Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 2-5 (IGLV2-5) is a human pseudogene belonging to the immunoglobulin lambda variable (IGLV) gene family, which ordinarily encodes variable domains of antibody light chains. As a pseudogene, IGLV2-5 does not produce a functional protein product and plays no active role in the immune response or antibody formation. It is part of the lambda light chain locus that includes both functional and non-functional (pseudo)genes. The functional IGLV genes contribute to the diversity of antibody recognition, but IGLV2-5 has lost coding potential due to disabling mutations. It is not regarded as a receptor, enzyme, or any other canonical druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 2-5 (IGLV2-5).